甘氨酸
博莱霉素
丝氨酸
肺
新陈代谢
特发性肺纤维化
肺纤维化
线粒体
化学
纤维化
生物化学
细胞生物学
成纤维细胞
蛋白质生物合成
胞浆
氨基酸
分子生物学
细胞
生物
生物合成
甘氨酸裂解系统
嘌呤代谢
癌症研究
细胞生长
细胞代谢
细胞培养
作者
Angelo Y. Meliton,Kun Woo D Shin,Rengül Çetin-Atalay,Volkan Atalay,Yufeng Tian,J. Szafran,Takugo Cho,Kaitlyn A. Sun,Parker S. Woods,O.R. Shamaa,B. Chen,Nickolai O. Dulin,Aliya N. Husain,Alexander Muir,Hardik Shah,Gökhan M. Mutlu,Robert B. Hamanaka
标识
DOI:10.1038/s41467-025-64320-2
摘要
TGF-β-dependent activation of lung fibroblasts is a hallmark of Idiopathic Pulmonary Fibrosis (IPF) which results in excessive collagen deposition and progressive scarring. Collagen production by lung fibroblasts is supported by de novo synthesis of glycine, the most abundant amino acid in collagen protein. SHMT2 produces glycine by transferring a one-carbon (1 C) unit from serine to tetrahydrofolate (THF), producing 5,10-methylene-THF (meTHF). meTHF is then converted back to THF in the mitochondrial 1 C pathway. It is unknown how 1 C metabolism contributes to collagen protein production and fibrosis. Here, we demonstrate that TGF-β induces the expression of mitochondrial 1 C pathway enzymes, including MTHFD2, in human lung fibroblasts. MTHFD2 was required for TGF-β-induced cellular glycine accumulation and collagen protein production in lung fibroblasts. Pharmacologic inhibition of MTHFD2 ameliorated fibrotic responses after intratracheal bleomycin instillation in vivo. Our findings suggest that mitochondrial 1 C metabolism is a therapeutic target for IPF and other fibrotic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI